AMBRA1 E3リガースアダプターは,サイクリンDの安定性を調節する
Andrea C Chaikovsky1,2, Chuan Li3, Edwin E Jeng2
1Department of Pediatrics, Stanford University, Stanford, CA, USA.
Nature
|April 15, 2021
まとめ
オートファジーとベクリン 1 調節器 1 (AMBRA1) は,分解のためにそれをマークすることによって,サイクリン D レベルを制御します. AMBRA1の減少はサイクリンDを増加させ,がんの成長を促進し,CDK4/ 6阻害剤に対する感受性を低下させます.
科学分野:
- 細胞生物学
- 分子生物学
- 腫瘍学
背景:
- D型サイクリン (サイクリンD) をDNA複製に結びつける細胞のインプットを統合する.
- 細胞増殖が制御されないため,サイクリンD- CDK4/ 6の活性が増加することが癌と関連している.
- サイクリンDのレベルを調節するメカニズムは,まだ完全に理解されていません.
研究 の 目的:
- サイクリンDの分解の主要レギュレータを特定する
- 細胞サイクル制御と癌におけるAMBRA1の役割を調査する.
- CDK4/ 6 阻害剤に対するAMBRA1の影響を理解する.
主な方法:
- CDK4/ 6抑制反応のレギュレータを特定するための全ゲノム遺伝子スクリーニング.
- 細胞とマウスのモデルで,AMBRA1喪失の影響を評価する.
- サイクリンDの分解メカニズムの解明のための生化学的分析
主要な成果:
- AMBRA1は,サイクリンDの分解の主なレギュレータとして特定されました.
- AMBRA1の喪失は,サイクリンD濃度の上昇につながり,増殖を促進し,CDK4/ 6抑制に対する感受性を低下させます.
- AMBRA1はCUL4 E3リガゼ複合体の基板受容体として作用し,サイクリンDの普遍化とタンパク質分解を媒介する.
結論:
- AMBRA1は細胞のサイクリンDレベルを決定的に調節する.
- AMBRA1の喪失は,マウスの肺腺癌の成長を促進する.
- 低レベルのAMBRA1は肺腺がん患者の生存率の低下と相関しており,がんの発症と治療反応の役割を示唆している.
さらに関連する動画
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
10.7K
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
14.6K
関連する概念動画
00:50Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
02:39Positive Regulator Molecules
6.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.0K
01:45Positive Regulator Molecules
117.0K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
117.0K
02:17Separation of Sister Chromatids
4.0K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.0K
02:15M-Cdk Drives Transition Into Mitosis
5.9K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.9K
02:34Inhibition of Cdk Activity
5.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K